This month, the Centers for Medicare and Medicaid Services will begin meeting with patients who use the 15 drugs it selected ...

What a pity that a Republican administration needs to be reminded that this misguided policy won’t make America healthy or ...

A new analysis looked at estimated out-of-pocket costs for etanercept, ustekinumab, and ibrutinib, specialty drugs that often ...

For decades, Americans have been overpaying for prescriptions and subsidizing innovation for the rest of the world. The White ...

President Donald Trump put the pharmaceutical industry on notice early Monday with the signing of his "most favored nation" ...

From sweeping drug price reforms to proposed staffing mandates and changes to Medicaid financing, here are five federal policy moves from the last week that ASCs need to know: CMS proposes updates for ...

For many children growing up in conservative evangelical Christian households in the 1990s, Saturday morning cartoons were ...

Pharmacy benefit managers face new compensation restrictions and transparency rules from the sweeping reconciliation budget ...

Novo Nordisk announced on Friday morning that its CEO Lars Fruergaard Jørgensen is stepping down after leading the company for eight years. In a release announcing the decision, the Danish pharma ...

Big promise, big problems: The biggest hurdles are data access and interoperability, said Hammad Shahid, head of Europe, Middle East and Africa data strategy at Johnson & Johnson in Belgium, at the ...

Stocks closed solidly higher on Friday, pushing major indexes to big weekly gains for the third time in the last four weeks.

Novo Nordisk CEO Lars Fruergaard Jørgensen is stepping down as the Danish drug giant faces increased competition for its ...